Titomic (ASX:TTT) signed a teaming agreement with REPKON USA, which replaces the previously agreed Turkish joint venture agreement and establishes a US framework to leverage Titomic's kinetic fusion cold spray technology in REPKON USA's existing product lines, according to a Tuesday Australian bourse filing/
Under the agreement, Titomic and the advanced metal and defense manufacturer will engage in joint research, development, and testing of kinetic fusion cold spray applications in cannon barrels, gun barrels, and warheads. Titomic will also work with REPKON to leverage the technology for the repair of assets in the field.
Titomic will partner on coatings of the REPKON barrels to provide increased performance moving forward.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。